J Biol Chem, Vol. 275, Issue 5, 3493-3500, February 4, 2000
Regulation of Dinitrogenase Reductase ADP-ribosyltransferase
and Dinitrogenase Reductase-activating Glycohydrolase by a
Redox-dependent Conformational Change of Nitrogenase Fe
Protein*
Cale M.
Halbleib
,
Yaoping
Zhang, and
Paul W.
Ludden§
From the Department of Biochemistry and Center for the Study of
Nitrogen Fixation, University of Wisconsin,
Madison, Wisconsin 53706
 |
ABSTRACT |
The nitrogenase-regulating enzymes dinitrogenase
reductase ADP-ribosyltransferase (DRAT) and dinitrogenase
reductase-activating glycohydrolase (DRAG), from Rhodospirillum
rubrum, were shown to be sensitive to the redox status of the
[Fe4S4]1+/2+ cluster of
nitrogenase Fe protein from R. rubrum or Azotobacter vinelandii. DRAG had <2% activity with oxidized R. rubrum Fe protein relative to activity with reduced Fe protein.
The activity of DRAG with oxygen-denatured Fe protein or a low
molecular weight substrate,
N
-dansyl-N
-(1,N6-etheno-ADP-ribosyl)-arginine
methyl ester, was independent of redox potential. The redox midpoint
potential of DRAG activation of Fe protein was
430 mV
versus standard hydrogen electrode, coinciding with the
midpoint potential of the [Fe4S4] cluster from R. rubrum Fe protein. DRAT was found to have a
specificity opposite that of DRAG, exhibiting low (<20%) activity
with 87% reduced R. rubrum Fe protein relative to activity
with fully oxidized Fe protein. A mutant of R. rubrum in
which the rate of oxidation of Fe protein was substantially decreased
had a markedly slower rate of ADP-ribosylation in vivo in
response to 10 mM NH4Cl or darkness stimulus.
It is concluded that the redox state of Fe protein plays a significant
role in regulation of the activities of DRAT and DRAG in
vivo.
 |
INTRODUCTION |
Nitrogen fixation requires the transfer of single electrons
through a series of redox-active metalloproteins. The oxidation states
and reduction potentials of these metalloproteins have been the
subjects of extensive research in the nitrogenase field (1). The
nitrogenase enzyme itself is composed of two highly conserved
iron-sulfur proteins, designated Fe
protein1 and MoFe protein. Fe
protein is a 64-kDa homodimer, containing a single
[Fe4S4] cluster, bound between the subunits
by symmetrical cysteinyl ligation (2, 3). MoFe protein is a 230-kDa
2
2 tetramer, containing two
[Fe8S7] clusters (P-clusters) located at the
interface of each 
dimer and two
molybdenum-iron-sulfur-homocitrate clusters (iron-molybdenum cofactor),
the presumed sites of substrate reduction (4-6). For any of the
substrates of nitrogenase, including dinitrogen, acetylene, and protons
(7, 8), electron transfer is coupled with the hydrolysis of at least
two MgATP molecules per electron (9).
Although the details of the nitrogenase catalysis model continue to be
debated, there is general agreement on the basic sequence of the cycle,
based on data obtained with both the Klebsiella pneumoniae
system and the Azotobacter vinelandii system. Fe protein, containing the reduced (1+) form of the
[Fe4S4] cluster, binds two MgATP molecules
(10). The binding of this nucleotide shifts the redox potential of the
[Fe4S4]2+/1+ couple from about
300 mV to nearly
450 mV (11, 12) and also elicits a specific
conformational change in Fe protein (13), promoting its association
with MoFe protein. An additional conformational change apparently
occurs upon complex formation, shifting the Fe protein redox potential
by an additional
200 mV (14) and allowing the transfer of a single
electron from the Fe protein to a iron-molybdenum cofactor of MoFe
protein, via a P-cluster (15, 16). Coupled to electron transfer is the
hydrolysis of the two MgATP molecules bound to Fe protein to MgADP and
Pi. ATP hydrolysis apparently serves to prevent the reverse
flow of electrons, rather than to drive electron transfer (17), as
single electron transfer without MgATP hydrolysis has been observed in
a tight-binding complex of MoFe protein with a variant of Fe protein
from an A. vinelandii mutant (18). Oxidized
([Fe4S4]2+) Fe protein,
stabilized by the two MgADP molecules still bound (19), dissociates
from one-electron-reduced MoFe protein in what is generally thought to
be the rate-limiting step of the cycle (20). To complete the cycle, Fe
protein is reduced by a low potential electron donor (a ferredoxin or
flavodoxin in vivo) and the MgADP molecules are exchanged
for two MgATP molecules. The catalytic cycle is repeated until a
sufficient number of electrons have been transferred to completely
reduce the FeMoco-bound substrate (21). As can be seen in the catalysis
description, the multifunctional Fe protein (which also has roles in
MoFe protein metallocluster synthesis (22, 23)) exists in several
distinct redox and conformational states during a single enzyme
turnover event.
In the nitrogen-fixing, photosynthetic, facultative anaerobe
Rhodospirillum rubrum, nitrogenase can be rapidly,
reversibly inactivated by mono-ADP-ribosylation of nitrogenase Fe
protein (24). This modification event occurs in response to
environmental conditions of fixed nitrogen sufficiency or of darkness,
when the energy-expensive nitrogenase reaction is undesirable (24). The
ADP-ribosylation of a specific arginine residue (Arg-101 in R. rubrum Fe protein) is catalyzed by dinitrogenase reductase ADP-ribosyltransferase (DRAT), using NAD+ as the ADP-ribose
donor (25, 26). The ADP-ribosylated Fe protein cannot reduce MoFe
protein, although the [Fe4S4] cluster is
still accessible to small redox-active molecules. DRAT acts as a 30-kDa
monomer with high specificity toward MgADP-bound Fe protein, possessing
no measurable activity with other arginine residues or water as the
ADP-ribose acceptor (27, 28). Surprisingly, the Fe proteins from
K. pneumoniae and A. vinelandii (which lack the
dra operon) are better substrates for R. rubrum
DRAT than the R. rubrum Fe protein itself. There are no
measurable reverse or glycohydrolytic reactions catalyzed by DRAT. The
removal of the ADP-ribose group is instead catalyzed by dinitrogenase
reductase-activating glycohydrolase (DRAG), which restores fully active
Fe protein with an intact Arg-101 side chain. DRAG is a 32-kDa
monomeric binuclear manganese enzyme that is capable of cleaving the
-N-glycosidic bond of a number of analogs of
ADP-ribosylarginine (29, 30). However, only the MgATP-bound form (not
the MgADP-bound or nucleotide-free forms) of ADP-ribosylated Fe protein
is a substrate for DRAG (31). Although the exact modes of interaction
of DRAT and DRAG with Fe protein are unknown, it is believed that each
binds the same surface of Fe protein as does MoFe protein, as evidenced
by the inhibition of cellular nitrogenase activity by overexpressed
DRAT (32).
Although the means by which DRAT and DRAG are each regulated are not
well understood, it is known that the activity of each enzyme is
regulated in vivo (33, 34). As the in vivo
activation and inactivation rates are reflected by in vitro
assay rates using purified components, it is believed that the
regulatory signals involve either negative effectors or known assay
components. As noted above, DRAT and DRAG have opposite specificities
for MgADP- and MgATP-bound Fe protein. However, cellular fluctuations
in ATP and ADP levels during inactivation/activation cycles are
insufficient to account for the dramatic nitrogenase activity
regulation (35). The cellular NAD+ concentration has also
been suggested as a possible positive effector for DRAT (36, 37).
Similarly, studies proposing regulation of DRAG via membrane
sequestration or activation have not yielded persuasive data (38, 39).
In this report, we demonstrate that the redox state of Fe protein
controls the activity of DRAT and DRAG. The alteration of in
vivo DRAT activity in a R. rubrum mutant in which Fe
protein is trapped in the reduced state is shown. We also discuss the
ramifications of these findings on the understanding of the
ADP-ribosylation and nitrogenase catalytic models.
 |
MATERIALS AND METHODS |
Bacterial Strains and Growth--
R. rubrum strains
UR2 (wild-type, Smr (40)), UR212
(draT::kan (34)), UR276 (wild-type, with
draG expressed from nifH promoter in a multicopy
plasmid (41)), and UR356 (wild-type, with draTGB expressed
from nifH promoter in a multicopy plasmid (32)) were each
grown in 20-liter fermentors on Ormerod's medium (42) modified as
described (33, 40).
Protein Purification--
Nitrogenase MoFe protein was purified
from UR2 (wild-type R. rubrum) cells (broken by the French
press method) as described (43). ADP-ribosylated Fe protein was
purified from UR2 cells by a modification of the described method (44),
in which a G-75 Sephadex gel filtration column (2.5 × 70 cm;
Amersham Pharmacia Biotech) was used instead of the preparative gel
step. Unmodified (active) Fe protein was purified from UR212
(DRAT
) cells with an identical protocol. DRAG was
purified from UR276 (draG overexpresser) cells as described
(39). DRAT was purified as described (44), from UR356
(draTGB overexpresser) cells broken by the French press method.
Fluorescent DRAG Substrate
Synthesis--
N
-Dansyl-N
-(1,N6-etheno-ADP-ribosyl)-arginine
methyl ester (
-ADPR-DAME) was synthesized and purified as described
previously (30, 45).
Oxidation of Fe Protein--
Fe protein, containing 1.7 mM sodium dithionite
(Na2S2O4; Fluka) as isolated, was
oxidized by indigo carmine (Sigma) bound to a Dowex chloride anion
exchange column (10). In a VAC Atmospheres anaerobic glove box, an
AG1-X8 Dowex chloride column (2 ml; Bio-Rad) was carefully poured on
top of a small layer of G-25 Sephadex resin (0.2 ml; Amersham Pharmacia
Biotech). Indigo carmine (1 ml of 20 mM) was bound to the
AG1-X8 resin. The column was equilibrated with 20 volumes of anaerobic
50 mM MOPS, pH 7.8. Fe protein (1-5 mg; 3-10 mg/ml) was
passed over the column, eluting in the equilibration buffer. The white
color of the G-25 layer of the column allowed visualization of the
brown Fe protein band eluting from the column. Indigo carmine-oxidized
Fe protein was found to be >95% active.
Decoupled DRAG Assays--
DRAG activity was determined by a
modification of the nitrogenase-coupled DRAG assay (29), in which the
removal of ADP-ribose was differentiated from the acetylene reduction
reaction. The standard demodification step was conducted in an
anaerobic, stoppered vial containing 5 mM ATP, 25 mM phosphocreatine, 50 µg of creatine phosphokinase
(Sigma), 25 mM MgCl2, 0.5 mM
MnCl2, 10 mM
Na2S2O4, 20-40 µg of
ADP-ribosylated Fe protein, 350 ng of DRAG, and 50 mM MOPS,
pH 7.8, in a 500-µl total volume under nitrogen headspace. Na2S2O4 or ATP were excluded from
some assays. After a 10-min incubation at 30 °C, 2 mM
ADP-ribose (Sigma) was added to inhibit further DRAG activity. The
acetylene reduction step was initiated by the addition of any
components excluded from the demodification step, along with 75 µg of
MoFe protein and 10% acetylene in the headspace. After a 10-min
incubation at 30 °C, the reaction was stopped by the addition of 5%
trichloroacetic acid. The headspace was analyzed for
C2H4 content by gas chromatography.
DRAG Assays by SDS-Polyacrylamide Gel Electrophoresis
Analysis--
Reactions were conducted in 50-µl volumes in
microcentrifuge tubes inside anaerobic, N2-filled vials.
Inside the vials, but outside the reaction tubes, 0.5 ml of 100 mM Na2S2O4 was present to act as an oxygen scavenger (26). Component concentrations were
identical to those in the decoupled DRAG assays described above, with
the following exceptions: creatine phosphokinase (2.5 µg),
ADP-ribosylated Fe protein (35 µg), and DRAG (200 ng). The reactions
were incubated 10 min at 30 °C and then were stopped by the addition
of 50 µl of SDS sample buffer. A sample (20 µl) of each stopped
assay was loaded onto a 10% acrylamide (0.6% bis-acrylamide) SDS
minigel. After electrophoresis, each gel was stained with Coomassie
Blue R-250 stain (Sigma). The relative amounts of the Fe protein upper
band (ADP-ribosylated) and lower band (unmodified) were quantitated by
ImageQuant software (Molecular Dynamics). A standard correction was
made in each assay for a contaminant of creatine phosphokinase, which
comigrated with the upper band of Fe protein. Note that only one
subunit of the Fe protein homodimer becomes ADP-ribosylated, and thus a
1:1 ratio of upper to lower band represents completely modified
(inactive) Fe protein dimer.
Fluorometric Assay for DRAG Activity--
A continuous assay for
DRAG cleavage of the N-glycosidic bond of
-ADPR-DAME has
been described (45). Assays were performed in 5-mm (outer
diameter) × 3.5-cm sealed quartz tubes. Reaction mixtures
contained 50 mM MOPS, pH 7.8, 1 mM
MnCl2, 50 µM
-ADPR-DAME, and 150 ng of
purified DRAG in a total volume of 250 µl. Reactions were conducted
anaerobically in the presence or absence of 0.5 mM
Na2S2O4. The reactions were
irradiated with 304 nm UV light, and the fluorescence emission at 405 nm was monitored. Reactions were initiated by the addition of DRAG.
After 3.5 h, 1 µg of phosphodiesterase (Sigma) and 0.5 mM MgCl2 were added to completely cleave all
ADP-ribosylarginine bonds. Finally, each reaction was exposed to air
for 20 min, to react away dithionite, before obtaining the final
fluorescence intensities.
DRAG Reaction Redox Dependence Determination--
The extent of
DRAG activity toward ADP-ribosylated Fe protein was determined in
reactions poised at varied redox potentials. In an anaerobic glove box,
DRAG decoupled assays (500 µl total volume) were set up, as described
above, containing 1 mM benzyl viologen (Sigma). High
concentrations of indigo carmine-oxidized ADP-ribosylated Fe protein
(100-300 µg/reaction) were required in these assays. Reactions were
poised by the addition of Na2S2O4, and the redox potentials were measured by direct potentiometry, using a
saturated Ag/AgCl2 electrode (Em°' = +199 mV versus standard hydrogen electrode (SHE)) as a
reference. Reactions were initiated by the addition of 150 ng of DRAG.
After a 10-min incubation, the redox potentials were again measured,
and the reactions were stopped by the addition of 2 mM
ADP-ribose. Because benzyl viologen inhibits nitrogenase reactions at
concentrations greater than 0.1 mM, portions of the stopped
assays (50 µl) were diluted 10-fold into acetylene reduction
reactions. The acetylene reduction assays contained 5 mM
ATP, 25 mM phosphocreatine, 50 µg of creatine
phosphokinase, 10 mM MgCl2, 2 mM
ADP-ribose, 10 mM
Na2S2O4, 75 µg of MoFe protein,
and 50 mM MOPS, pH 7.8, under a headspace of 10% acetylene
in nitrogen. The reactions were incubated for 10 min at 30 °C and
then were stopped by the addition of 5% trichloroacetic acid. The
headspace was analyzed for C2H4 content by gas chromatography.
R. rubrum Fe Protein Midpoint Potential Determination--
The
midpoint potentials for modified and unmodified R. rubrum Fe
protein were determined by dye-mediated, visible spectrum-monitored redox titration. Two solutions in matched glass cuvettes were prepared,
containing 50 µM Fe protein, 50 mM MOPS, pH
7.8, 3 mM MgATP, and 15 µM methyl viologen
(MV) (Sigma). The spectral differences between the cuvettes were
recorded as 2-µl aliquots of 2 mM
Na2S2O4 were added to one cuvette.
The redox potential of the titrated solution was determined from the
intensity of the absorption at 608 nm due to reduced MV. The fraction
of Fe protein in the reduced ([Fe4S4]1+) state was determined
from the change in the characteristic Fe protein absorbance at 420 nm
(46, 47).
DRAT Assays under Reducing or Oxidizing Conditions--
An assay
for DRAT activity by 32P-NAD radiolabeling of Fe protein
has been described (28). The standard reaction mix contains 50 mM MOPS, pH 7.8, 1 mM ADP, 5 mM
MgCl2, 0.25 mM [
-32P]NAD (20 µCi/µmol), 80 µg of indigo carmine-oxidized, unmodified Fe
protein, and DRAT in a volume of 50 µl. To this mix were added 10 µM MV and 4 µg of carbon monoxide dehydrogenase (CODH)
from R. rubrum. To produce reducing conditions, the
headspace of the reaction vial was filled with CO, which was oxidized
to CO2 by CODH with a concomitant reduction of MV. Assay
mixtures were incubated for 20 min at 30 °C and then were stopped
with 5% trichloroacetic acid. Precipitated protein was collected on
nitrocellulose filters, and the amount of
[
-32P]ADP-ribose incorporated into Fe protein was
determined by a Packard Tri-Carb 2100TR liquid scintillation counter.
ADP-ribosylation Analysis in R. rubrum Whole Cells--
R.
rubrum strains UR2 (wild-type) and UR145
(nifD::kan (48)) were grown on supplemented
malate-ammonium medium (40). Each strain was inoculated into
malate-glutamate medium (33) at a 65-fold dilution. After illuminated,
anaerobic growth for 2 days, for derepression of Fe protein, the cells
were treated with darkness or 10 mM NH4Cl, as
described (33). Proteins were extracted quickly by a trichloroacetic
acid precipitation method (49, 50). Fe protein subunits were separated
by electrophoresis on a 10% acrylamide (0.6% bis-acrylamide) SDS
minigel. Proteins from SDS-polyacrylamide gel electrophoresis were
transferred onto nitrocellulose and then were immunoblotted with
polyclonal antibody against A. vinelandii Fe protein and
were visualized with ECL Western blotting reagents (Amersham Pharmacia
Biotech). The protein bands on the x-ray film were quantitated by
ImageQuant software.
 |
RESULTS |
Requirement for Reductant in DRAG Reactions with Fe
Protein--
The activation of ADP-ribosylated Fe protein by DRAG was
assayed with oxidized Fe protein or reduced Fe protein by the
"decoupled DRAG assay" described under "Materials and Methods."
In both cases, Fe protein was first oxidized as described under
"Materials and Methods." To obtain reduced Fe protein, sodium
dithionite was added to the incubation mixture. In the second phase of
the decoupled DRAG assay, the extent of activation of Fe protein was
determined from acetylene reduction assays conducted in the presence of
MoFe protein, excess dithionite, and 10% acetylene in the headspace. In these decoupled assays for DRAG activity, with indigo
carmine-oxidized Fe protein from R. rubrum as the substrate,
activity in the absence of Na2S2O4
was found to be negligible in comparison to activity with the reductant
added (Table I). This result was
validated by demonstration of the efficacy of the assay system. In the
decoupled assays, the addition of 2 mM ADP-ribose
completely inhibited DRAG activity but only slightly inhibited the
acetylene reduction reaction of Fe protein and MoFe protein (data not
shown). The addition of this specific inhibitor stopped DRAG activation
of Fe protein, effectively separating the DRAG-dependent
activation of Fe protein from the Fe protein-dependent
acetylene reduction phase of the assay and thus allowing analysis of
the DRAG reaction in isolation. The decoupled assay system was
demonstrated to be a linear assay for DRAG. The dependence of the DRAG
reaction on the presence of MgATP, first reported by Saari et
al. (31), was confirmed (Table I). Also, the dependence on
reductant was shown to exist regardless of the divalent cation
(Mn2+ or Fe2+) present in the assay (data not
shown).
The stimulation of DRAG activity by reductant was correlated to a
change in Fe protein subunit composition, indicative of the removal of
ADP-ribose from Fe protein (51, 52). In SDS-polyacrylamide gel
electrophoresis, ADP-ribosylated subunits of Fe protein run anomalously
slowly, allowing differentiation from unmodified subunits. The
conversion of upper (ADP-ribosylated) to lower (unmodified) band was
monitored by laser densitometry of Coomassie Blue-stained gels. These
demodification assays, described under "Materials and Methods,"
were conducted under conditions similar to those of the decoupled assay
but did not require the addition of acetylene reduction reaction
components. In the presence of a complete reaction mix, including
sodium dithionite, nearly half of the Fe protein was converted from the
modified to the unmodified band in a 10 min assay (Fig.
1A). This conversion
represents roughly 90% of the total possible subunit conversion, as
~50% of the N-glycosidic bonds liking ADP-ribose to Fe
protein are in the
-configuration and thus are unreactive toward
DRAG (52). When the system was oxidized by the addition of indigo
carmine, little conversion to the lower band was observed. The absence
of MgATP also prevented subunit conversion. Protein band densities were
corrected for background in the absence of Fe protein (Fig. 1A,
lane 1). The demodification assay was shown to be inhibited by 200 mM NaCl and 1 mM ADP-ribose by 59 and 61%,
respectively, in close agreement to values reported by Saari et
al. (31) for the DRAG radioassay.

View larger version (31K):
[in this window]
[in a new window]
|
Fig. 1.
Analysis of DRAG activity by Fe protein
subunit composition. After 10 min of reaction with DRAG at
30 °C, modified Fe protein was differentiated from unmodified Fe
protein by SDS-polyacrylamide gel electrophoresis, as described under
"Materials and Methods." Conversion of upper subunit to lower
subunit Fe protein directly measures DRAG activity. A,
Coomassie Blue-stained gel of reactions with native R. rubrum Fe protein. Lane 1 contains the background
proteins present in the absence of Fe protein. Lane 2 contains unreacted Fe protein. Lanes 3-6 contain reactions
of Fe protein with DRAG. Lane 3 contains the reaction in the
presence of complete incubation conditions. In lanes 5 and
6, reactions excluded MgATP, phosphocreatine, and creatine
phosphokinase. In lanes 4 and 6, indigo carmine
(Em°' = 125 mV versus SHE) was added
until blue color persisted. n/a, not applicable.
B, Coomassie Blue-stained gel of reactions with
O2-denatured R. rubrum Fe protein. Fe protein
was exposed to air for 30 min and then was made anaerobic by degassing
and flushing with N2, before addition to reaction.
Lanes 1 and 2 are controls as described for
A. Lane 3 represents the reaction with DRAG in
the presence of Na2S2O4 and MgATP.
In lanes 4 and 6, Na2S2O4 was excluded. In
lanes 5 and 6, reactions excluded MgATP,
phosphocreatine, and creatine phosphokinase.
|
|
Identification of the Redox-sensitive Species in DRAG
Reactions--
The studies above indicated that low redox potential
was required for DRAG activity, but it was unknown whether low
potential was required for reduction of DRAG, for reduction of Fe
protein, or for the reaction chemistry. This question was answered by
investigating reactions of DRAG with alternative substrates. The first
such substrate was reduced Fe protein, from which excess
Na2S2O4 was removed by desalting on
a gel filtration column (Table I). The reduced Fe protein was found to
be activated to a similar extent as oxidized Fe protein when sodium
dithionite was present (fully reducing Fe protein in each case).
However, in the absence of additional reductant, significant activity
(21% of maximum) was still observed with reduced Fe protein.
Correspondingly, the desalted Fe protein was found to be only 37%
reduced by visible spectroscopy. Despite the loss of activity,
presumably due to the observed oxidation, the ability of the desalted,
reduced Fe protein to act as a DRAG substrate suggested a role of the
redox state of Fe protein in controlling de-ADP-ribosylation by
DRAG.
The second substrate examined was O2-denatured Fe protein.
This irreversibly damaged Fe protein is iron-free and is thought to
exist as a denatured polymer of Fe protein monomers (46). Previously,
the activity of DRAG with denatured Fe protein was shown to be similar
to that with native Fe protein, but with no requirement for MgATP (31).
All previously published data have corroborated the model of
ADP-ribosylated, O2-denatured Fe protein as an
effector-insensitive peptide. In demodification assays identical to
those tested for native Fe protein, DRAG was shown to have full
activity toward denatured Fe protein in the presence or absence of
dithionite and in the presence or absence of MgATP (Fig.
1B). Reactions with denatured Fe protein were shown to be
insensitive to NaCl but inhibited by ADP-ribose, verifying published
data (31). It was noted that the presence of a fraction of Fe protein in the denatured form may have been responsible for the small activities seen in reactions of DRAG with native Fe protein in the
absence of MgATP or Na2S2O4 (Fig.
1A, lanes 4-6).
A third substrate of DRAG assayed for redox potential effect was
-ADPR-DAME. With this fluorescent substrate, the DRAG reaction has a
Vmax similar to that with ADP-ribosylated Fe
protein (30). Cleavage of the ADP-ribosylarginine bond of
-ADPR-DAME
by DRAG was monitored by the intensity of fluorescence of the
unquenched etheno-adenine group at 405 nm. The reaction curves in the
presence or absence of 0.5 mM sodium dithionite are very
similar (Fig. 2). After 3.5 h of
reaction with DRAG, fluorescence equaled 41 and 36% (with and without
dithionite, respectively) of the maximal fluorescence observed after
treatment with phosphodiesterase. These values are consistent with the
40% value observed by Pope et al. (45) in the presence of
dithionite. The difference in total fluorescence intensities was
attributed to absorption of the excitation energy at 304 nm by
dithionite (
max = 310 nm). After oxidation by air, the
final fluorescence intensities were identical (Fig. 2). Along with the
denatured Fe protein data, the insensitivity of the fluorometric assay
toward dithionite indicated that the requirement of DRAG for low redox
potential occurs in response to a change of native Fe protein.

View larger version (15K):
[in this window]
[in a new window]
|
Fig. 2.
Reaction of DRAG with
-ADPR-DAME. Fluorescence intensity of
etheno-adenine moiety released from the DAME group by DRAG was
monitored in the absence (trace 1) or presence (trace
2) of 0.5 mM
Na2S2O4. Treatment with
phosphodiesterase released all -adenine. After O2
treatment, total fluorescence in each reaction cuvette was
determined.
|
|
To verify the hypothesis that DRAG was sensitive to the redox state of
the [Fe4S4] cluster of Fe protein, the
midpoint potential of Fe protein and the redox dependence of the
activation reaction with DRAG were determined. The midpoint potential
of the [Fe4S4] cluster of Fe protein in the
presence of 3 mM MgATP was determined by visible
spectroscopy, using the A608 of the redox buffer, methyl viologen (Em°' =
446 mV versus SHE),
as a standard. The resulting data predict a midpoint potential of
470 ± 1 mV (versus SHE) and n = 0.73 ± 0.03. The Fe protein midpoint potential was unaffected by
ADP-ribosylation (inactive Fe protein Em =
471 ± 1 mV, n = 0.80 ± 0.02). For the
DRAG activation reactions, a variation of the decoupled DRAG assay was
performed, in which the reactions with DRAG were poised at directly
measured redox potentials in the presence of a redox dye (benzyl
viologen, Em°' =
325 mV versus SHE).
After the DRAG reaction was stopped, a fraction of each reaction was
injected into a standard nitrogenase assay. The activation of Fe
protein by DRAG follows the redox state of the
Fe4S4 cluster of Fe protein (Fig.
3). Given the relative proximity of the
two redox-dependent phenomena, it seems likely that the
change of Fe protein recognized by DRAG is, indeed, the change in redox
state of the [Fe4S4] cluster. Additionally,
A. vinelandii Fe protein that was 100% ADP-ribosylated by
extensive reaction with DRAT was tested for reaction with DRAG by the
DRAG activation protocol. The midpoint potential for this reaction was
~
440 mV, which is in close agreement with the published value of
430 mV for the midpoint potential of nucleotide-bound A. vinelandii Fe protein (11, 12).

View larger version (18K):
[in this window]
[in a new window]
|
Fig. 3.
Redox potential curves for Fe protein
Fe4S4 cluster reduction and activation by
DRAG. DRAG activities were determined at the indicated redox
potentials by decoupled DRAG assays. The DRAG activation data were
determined with 1 mM benzyl viologen ( ) as the redox
buffer, in addition to standard reaction components. Redox potentials
were measured by direct potentiometry. DRAG activities were normalized
to average activities of standard decoupled assays using freshly
oxidized Fe protein. The fraction of Fe protein reduced ( ) at poised
potentials was determined from the change in the characteristic Fe
protein absorbance at 420 nm. The redox potential of the titrated
solution was determined from the intensity of the absorption at 608 nm
due to reduced MV. The fraction of Fe protein reduced at each potential
was normalized to the predicted maximal value. The midpoint potential
of Fe protein (DRAG activation data excluded) was fitted with
least-square curves using Prism software, with both curve slope and
midpoint potential as parameters.
|
|
DRAT Reactions under Oxidizing or Reducing
Conditions--
Previous studies on the reaction of DRAT with
unmodified Fe protein have noted the deleterious effect of
Na2S2O4 (26), which apparently
reduces NAD+ to NADH; NADH does not serve as an ADP-ribose
donor in the DRAT-catalyzed modification of Fe protein. Therefore,
another reductant had to be found for examination of DRAT reactions
under reducing conditions. A coupled assay was developed in which CO,
the ultimate source of reducing power, is oxidized to CO2
by CODH, in the process reducing the redox dye MV. Thus MV
concentrations could be kept low to prevent inhibition of DRAT, while
maintaining a constant source of MV as a low potential reductant. Under
the reaction conditions, the redox states of NAD+ or NADH
are unaffected by the presence or absence of the reductant CO (Fig.
4A). Oxidized Fe protein is
unaffected by the presence of oxidized CODH and MV (Fig. 4B)
but is fully reduced when CO is added to the system. The ratio of
A430 for Fe protein (oxidizing conditions
versus reducing conditions) is 1.7, which is identical to
the ratio (1.7) reported by Ashby and Thorneley (10) for A. vinelandii Fe protein (87% reduced versus fully
oxidized).

View larger version (19K):
[in this window]
[in a new window]
|
Fig. 4.
Redox states of components of DRAT
reactions. Absorption spectra of NAD, NADH, or A. vinelandii Fe protein were recorded in reducing or oxidizing
conditions in the DRAT assay system (50 mM MOPS, pH 7.8, 1 mM ADP, 5 mM MgCl2, 0.25 mM NAD, 10 µM MV, 1 µM CODH,
and 40 µM indigo carmine-oxidized, unmodified Fe protein, ± saturating CO). Reference cuvettes contained solutions of all
components of the DRAT reaction mix, excluding DRAT and the assayed
component. A, spectra of 0.25 mM NAD or NADH, in
the region of the characteristic absorbance of NADH at 340 nm. Spectra
of NADH are shown in reaction mix in the presence (trace 1)
or absence (trace 2) of CO. A spectrum of genuine NADH
(trace 3) in 50 mM MOPS, pH 7.8, is also shown.
Spectra of NAD in the presence (trace 4) or absence
(trace 5) of CO are shown, with genuine NAD (trace
6) in 50 mM MOPS, pH 7.8, as a control. B,
spectra of 40 µM Fe protein in the absence (trace
1) or presence (trace 2) of CO, with the difference
spectrum (trace 3) exhibiting a characteristic maximum at
425 nm.
|
|
Using the CO/CODH/MV system as a source of reductant, the activity of
DRAT with oxidized or reduced Fe protein from R. rubrum or
A. vinelandii was examined by
32P-ADP-ribosylation assay (Table
II) or reversible inactivation of Fe
protein (Table III). In all cases, the
DRAT reaction with oxidized Fe protein was superior to the reaction
with reduced substrate. In the reaction of DRAT with reduced R. rubrum Fe protein (Table II), significant ADP-ribosylation
activity (~15% of maximum) was observed. It is possible that some
label was deposited on CODH, as labeling is diminished in the absence
of CODH. Also, there was no reversible inactivation of R. rubrum Fe protein under reducing conditions (Table III),
suggesting that DRAT activity with reduced Fe protein is minimal. Under
oxidizing conditions, the DRAT reaction characteristics reflected
published data for the activity of DRAT (27, 28), with similar extent
of reaction under the given reaction conditions and a
Km for NAD+ of about 2 mM
(data not shown). Reactions with A. vinelandii Fe protein
achieved much more labeling and inactivation than with R. rubrum Fe protein, as noted previously (27). Although some DRAT
activity was seen in reducing conditions, reactions in oxidizing conditions resulted in greater labeling (Table II) and 100%
inactivation of Fe protein (Table III).
Effect of a nifD Mutation on ADP-Ribosylation of Fe Protein from R. rubrum--
The nifD gene encodes the
-subunit of the
MoFe protein. R. rubrum cells lacking nifD, grown
as described under "Materials and Methods," are incapable of the
reduction of nitrogen (48). The Fe protein in an R. rubrum
mutant (UR145) containing an insertion cassette in the nifD
gene was ADP-ribosylated more slowly in response to darkness or ammonia
than was Fe protein in wild-type cells (Fig.
5). In these experiments, the cells were
derepressed for nitrogenase expression on a medium with malate as the
major carbon source and glutamate as the nitrogen source. Under these
growth conditions, either removal from light or addition of 10 mM NH4Cl causes the loss of nitrogenase
activity due to inactivation of Fe protein by
DRAT-dependent ADP-ribosylation. Lacking the MoFe protein,
the UR145 mutant lacks the primary electron acceptor for Fe protein,
trapping the Fe protein in the reduced state.

View larger version (17K):
[in this window]
[in a new window]
|
Fig. 5.
Rate of "switch-off" in strain UR145
(nifD mutant) of R. rubrum. Bacterial cultures
were grown for 2 days on malate-glutamate medium to derepress
nitrogenase. Cultures were treated either with darkness (A)
or with 5 mM NH4Cl (B). The fraction
of Fe protein in active form was determined by Western blot analysis of
Fe protein subunit composition. Data represent responses of wild-type
UR2 ( ) or UR145 ( ).
|
|
 |
DISCUSSION |
We have demonstrated the sensitivity of the DRAT and DRAG
regulatory enzymes to the redox state of the substrate, Fe protein. In
previous studies of these enzymes, treatment of the regulatory and
substrate proteins precluded investigation of any redox effect. In the
case of DRAG, the enzyme was thought to be oxygen-labile until recently
(41), and the truly oxygen-labile substrate, Fe protein, was generally
handled and stored in the presence of Na2S2O4 as an oxygen scavenger.
Thus, DRAG reactions were always performed in the presence of the
strong reductant, sodium dithionite, creating the conditions required
for activity. In reactions with DRAT, it was recognized that the
reaction mix had to be treated with excess NAD+ to react
away all dithionite. However, the ability of dithionite to reduce
NAD+ masked the separate effect of activity inhibition
under reducing conditions.
In these studies, a pair of activity assays for DRAG was developed, in
which the activation of ADP-ribosylated Fe protein by DRAG could be
studied in isolation. In previous studies of DRAG, activity assays were
normally coupled directly with nitrogenase activity assays (29, 53,
54), which prevented investigation of the DRAG reaction requirements in
isolation. A direct assay for DRAG activity has also been reported
(31), in which the release of tritiated ADP-ribose from Fe protein is
measured. The decoupled DRAG assay, described under "Materials and
Methods," was shown to effectively separate the activation of Fe
protein from acetylene reduction by activated Fe protein in conjunction with MoFe protein. The demodification assay also allows the study of
DRAG activity in isolation. Both assays were shown to produce results
similar to those of the radioassay but offer the advantages of speed
and ease of implementation.
The salient discovery of this study is the demonstration that DRAG and
DRAT activities are sensitive to the redox state of Fe protein in
vitro. DRAG was clearly shown to have no activity with oxidized Fe
protein. Some DRAG activity was observed with isolated, reduced Fe
protein. This activity was limited by the fact that reduced Fe protein,
in the absence of excess reductant, becomes oxidized during handling.
It is not clear whether this oxidation occurs due to O2
leaking into the reaction vials or due to Fe protein oxidation in scant
dithionite solutions, noted by Watt et al. (12). As DRAG is
insensitive to redox poise in reactions with other ADP-ribosylarginine
substrates, it is concluded that DRAG senses the change in Fe protein
in the redox status of the
[Fe4S4]1+/2+ cluster. The
midpoint potential of DRAG activation was found to coincide with
the Fe protein midpoint. The midpoint potential of R. rubrum Fe protein in the presence of MgATP was determined to be
470 mV, which is comparable to the values reported for Fe proteins
from A. vinelandii (11, 12) and K. pneumoniae (55). DRAT was found to have a specificity for Fe protein opposite that
of DRAG, acting only upon the oxidized form of Fe protein. The
CO/CODH/MV reducing system was shown to reduce oxidized Fe protein
effectively, while leaving NAD+ unaffected. The small
amount of activity seen for R. rubrum Fe protein under
reducing conditions may be due either to nonspecific deposition of
32P label on CODH present in the assay, to a small (<10%)
fraction of Fe protein remaining oxidized, or to incomplete inhibition of DRAT under reducing conditions. We propose that DRAT recognizes the
same redox switch as DRAG, that is, the
[Fe4S4]1+/2+ switch in Fe protein.
The alteration of nitrogenase regulation in the nifD mutant
demonstrates the physiological relevance of these in vitro
studies. In R. rubrum, there are multiple low redox
potential electron donors to Fe
protein.2 However, MoFe
protein is the primary electron acceptor for Fe protein. Therefore, in
the UR145 mutant, oxidation of Fe protein is significantly inhibited,
presumably trapping the Fe protein in the reduced state. This result is
predicted by the data collected for in vitro DRAT and DRAG
reactions, which demonstrate less efficient ADP-ribosylation and more
efficient removal of ADP-ribose when Fe protein is predominantly
reduced. Note that the response curves to darkness and ammonia
treatment resemble those of wild-type except in the magnitude of
response. In response to the strong negative stimulus of darkness
treatment, transient DRAT activity is observed, followed by a leveling
of nitrogenase activity. In response to high levels of ammonia, the
inactivating response, although weaker than that of darkness, is
maintained for a much longer period of time (over 1 h). These
results are consistent with a model in which the signal transduction
pathways for regulation of DRAG and DRAT activity are unaltered in
UR145, but the fraction of Fe protein available for ADP-ribosylation is
reduced. It is not clear whether the slower rate of modification of Fe
protein in the nifD mutant is a result of decreased rate of
ADP-ribosylation, increased rate of removal of ADP-ribose, or a
combination of both. Future analysis of the turnover of label on Fe
protein will address this question.
The present study has a significant impact of the model for regulation
of nitrogenase in R. rubrum. It is clear that the model for
Fe protein regulation by ADP-ribosylation must address the availability
and state of the Fe protein for reactions of the regulatory enzymes. We
propose such a general model for the regulation of Fe protein
activity by ADP-ribosylation in R. rubrum (Fig. 6). Acceptance of this model prompts an
examination of previous results in this system. Johnson et
al. (56) have demonstrated that a significant portion of A. vinelandii Fe protein remains oxidized when reductant is limiting
in an in vitro assay system. If reducing power is also
limiting in vivo, it is likely that a mixture of reduced and
oxidized Fe protein is present at any given time. Analysis of previous
work (32) suggests that DRAT, even when inactive, may be associated
with oxidized, MgADP-bound Fe protein. The ability of reduced or
oxidized Fe protein to form such an inhibiting complex with DRAT,
without the ADP-ribosylation reaction occurring, may be studied
in vitro by protein-protein cross-linking, after the method
of Grunwald and Ludden (44). The inability of overexpressed DRAG to
inhibit active Fe protein (32) may be due to sequestration of
MgATP-bound Fe protein in complexes with MoFe protein. ADP-ribosylated,
inactive Fe protein may, on the other hand, be available for DRAG under
conditions conducive to nitrogenase and DRAG activity. Although the
possibility of change in cellular ATP/ADP ratios has been ruled out as
a regulatory signal to DRAT and DRAG (35), it is possible that local
changes in redox potential, along with variations in ATP/ADP ratios and NAD+ concentrations, may give rise to the dramatic
regulation observed for DRAT and DRAG in vivo.

View larger version (25K):
[in this window]
[in a new window]
|
Fig. 6.
Model of nitrogenase regulation in R. rubrum by reversible ADP-ribosylation of Fe
protein. In vivo regulation by DRAG and DRAT is
represented, incorporating the findings of the present study. The
redox-dependent conformational change of Fe protein is
shown by a shift in Fe protein subunit position. Also represented is
the position of the ADP-ribose moiety, near the
Fe4S4 cubane in Fe protein.
|
|
This study has also produced a result that is important to the
understanding of the general nitrogenase catalytic cycle in all
nitrogen-fixing organisms. Here, we clearly demonstrate that a
significant conformational change must occur in Fe protein in response
to the change in the redox state of the
[Fe4S4] cluster, independent of the
nucleotide-induced conformational change (55). Circular dichroism
studies of Fe protein, first reported by Stephens et al.
(13), have long been used to demonstrate a change in the environment of
the [Fe4S4] cluster upon reduction or
oxidation. However, these studies do not demonstrate a significant
change in the overall protein structure. The results here suggest that Fe protein exists in different conformations in the oxidized and reduced forms in the presence of excess MgATP. DRAG is able to cleave
the N-glycosidic bond that links ADP-ribose to Arg-101 only
when the Fe protein is in the reduced form with MgATP bound. Thus,
either DRAG cannot bind to the [Fe protein]ox·MgATP
complex due to a different conformation of the Fe protein or the
N-glycosidic bond is inaccessible to DRAG in a [Fe
protein]ox·MgATP·DRAG complex. Either possibility
demands that the conformation of [Fe protein]ox·MgATP be significantly different from [Fe protein]red·MgATP.
The conformational change in Fe protein concurrent with the change in
the Fe4S4 redox state is independent of the
nucleotide-dependent conformational change, as the redox
switch was observed in 5 mM MgATP, saturating for either
oxidized or reduced Fe protein (12, 57). The
redox-dependent conformational change may also explain the
difference in the affinity of [Fe protein]ox and [Fe
protein]red for MgADP and MgATP (12), as well as the
redox-dependent difference in accessibility of the
[Fe4S4] cluster to
,
'-dipyridyl
(58).
The differences observed between R. rubrum and A. vinelandii Fe proteins in these studies provide some insight into
the importance of subtle differences between these two very similar
enzymes. Although the sequence identity between these two proteins is
quite high, on the "upper" surface, the site of interaction with
MoFe and presumably with DRAG and DRAT, there are only three
differences in solvent-exposed residues. From the crystal
structure of A. vinelandii Fe protein, it can be seen that
Thr-66, Asn-173, and Ser-174 are exposed on the upper surface. These
residues are replaced by Ser-66, His-173, and Thr-174 in R. rubrum Fe protein. Whether it is the actual residue changes that
are critical, or rather subtle variations in the relative
positions of upper surface residues, the A. vinelandii Fe
protein is a significantly better substrate for DRAT than the natural
substrate, due in part to a lower apparent Km for
NAD+ (27). Here we have shown that DRAT still senses the
redox switch in A. vinelandii Fe protein but that the
inactivity toward reduced Fe protein is less strict than with R. rubrum Fe protein. Further studies are required to determine the
amino acid differences in A. vinelandii and R. rubrum Fe proteins that cause the different reactivities toward
DRAT. Interestingly, DRAG, which is generally less selective of its
substrates than is DRAT, retains absolute specificity for the reduced
form of A. vinelandii Fe protein. Thus, the significant
conformational change occurring upon change of the redox state of the
[Fe4S4] cluster is likely to be important in
all nitrogenase Fe proteins.
 |
ACKNOWLEDGEMENTS |
We gratefully acknowledge J. Heo for the
gift of CODH. We also recognize K. Strecker and J. Clark for
growth of R. rubrum cells. We thank G. Roberts
for critical reading of the manuscript and R. Watt for useful discussions.
 |
FOOTNOTES |
*
This work was supported in part by National Institute of
General Medical Science Grant GM54910 (to P. W. L.).The costs of publication of this
article were defrayed in part by the
payment of page charges. The article
must therefore be hereby marked
"advertisement" in
accordance with 18 U.S.C. Section
1734 solely to indicate this fact.
Trainee of the National Institutes of Health Biotechnology
Training Program; supported by National Institutes of Health Grant 5 T32 GM08349.
§
To whom correspondence should be addressed: Dept. of Biochemistry,
University of Wisconsin-Madison, 433 Babcock Dr., Madison, WI 53706.
Tel.: 608-262-6859; Fax: 608-262-3453; E-mail:
ludden@biochem.wisc.edu.
2
S. Nordlund, personal communication.
 |
ABBREVIATIONS |
The abbreviations used are:
Fe protein, iron
protein of nitrogenase;
MoFe protein, molybdenum-iron protein of
nitrogenase;
DRAT, dinitrogenase reductase ADP-ribosyltransferase;
DRAG, dinitrogenase reductase-activating glycohydrolase;
-ADPR-DAME, N
-dansyl-N
- (1,N6-etheno-ADP-ribosyl)-arginine
methyl ester;
dansyl, 5-dimethylaminonaphthalene-1-sulfonyl;
SHE, standard hydrogen electrode;
MV, methyl viologen;
CODH, carbon monoxide
dehydrogenase;
MOPS, 4-morpholinepropanesulfonic acid.
 |
REFERENCES |
| 1.
|
Howard, J. B.,
and Rees, D. C.
(1994)
Annu. Rev. Biochem.
63,
235-264[CrossRef][Medline]
[Order article via Infotrieve]
|
| 2.
|
Hausinger, R. P.,
and Howard, J. B.
(1983)
J. Biol. Chem.
258,
13486-13492[Abstract/Free Full Text]
|
| 3.
|
Georgiadis, M. M.,
Komiya, H.,
Chakrabarti, P.,
Woo, D.,
Kornuc, J. J.,
and Rees, D. C.
(1992)
Science
257,
1653-1659[Abstract/Free Full Text]
|
| 4.
|
Kim, J.,
and Rees, D. C.
(1992)
Science
257,
1677-1682[Abstract/Free Full Text]
|
| 5.
|
Shah, V. K.,
and Brill, W. J.
(1977)
Proc. Natl. Acad. Sci. U. S. A.
74,
3249-3253[Abstract/Free Full Text]
|
| 6.
|
Hawkes, T. R.,
McLean, P. A.,
and Smith, B. E.
(1984)
Biochem. J.
217,
317-321[Medline]
[Order article via Infotrieve]
|
| 7.
|
Stewart, W. P. D.,
Fitzgerald, G. P.,
and Burris, R. H.
(1967)
Proc. Natl. Acad. Sci. U. S. A.
58,
2071-2078[Free Full Text]
|
| 8.
|
Simpson, F. B.,
and Burris, R. H.
(1984)
Science
224,
1095-1097[Abstract/Free Full Text]
|
| 9.
|
Ljones, T.,
and Burris, R. H.
(1972)
Biochim. Biophys. Acta
275,
93-101[Medline]
[Order article via Infotrieve]
|
| 10.
|
Ashby, G. A.,
and Thorneley, R. N.
(1987)
Biochem. J.
246,
455-465[Medline]
[Order article via Infotrieve]
|
| 11.
|
Zumft, W. G.,
Mortenson, L. E.,
and Palmer, G.
(1974)
Eur. J. Biochem.
46,
525-535[Medline]
[Order article via Infotrieve]
|
| 12.
|
Watt, G. D.,
Wang, Z.-C.,
and Knotts, R. R.
(1986)
Biochemistry
25,
8156-8162[CrossRef]
|
| 13.
|
Stephens, P. J.,
McKenna, C. E.,
Smith, B. E.,
Nguyen, H. T.,
McKenna, M. C.,
Thomson, A. J.,
Devlin, F.,
and Jones, J. B.
(1979)
Proc. Natl. Acad. Sci. U. S. A.
76,
2585-2589[Abstract/Free Full Text]
|
| 14.
|
Lanzilotta, W. N.,
and Seefeldt, L. C.
(1997)
Biochemistry
36,
12976-12983[CrossRef][Medline]
[Order article via Infotrieve]
|
| 15.
|
Lowe, D. J.,
Fisher, K.,
and Thorneley, R. N.
(1993)
Biochem. J.
292,
93-98
|
| 16.
|
Peters, J. W.,
Fisher, K.,
Newton, W. E.,
and Dean, D. R.
(1995)
J. Biol. Chem.
270,
27007-27013[Abstract/Free Full Text]
|
| 17.
|
Lanzilotta, W. N.,
Parker, V. D.,
and Seefeldt, L. C.
(1998)
Biochemistry
37,
399-407[CrossRef][Medline]
[Order article via Infotrieve]
|
| 18.
|
Lanzilotta, W. N.,
Fisher, K.,
and Seefeldt, L. C.
(1996)
Biochemistry
35,
7188-7196[CrossRef][Medline]
[Order article via Infotrieve]
|
| 19.
|
Miller, R. W.,
Eady, R. R.,
Gormal, C.,
Fairhurst, S. A.,
and Smith, B. E.
(1998)
Biochem. J.
334,
601-607
|
| 20.
|
Thorneley, R. N.,
and Lowe, D. J.
(1983)
Biochem. J.
215,
393-403[Medline]
[Order article via Infotrieve]
|
| 21.
|
Hageman, R. V.,
and Burris, R. H.
(1978)
Proc. Natl. Acad. Sci. U. S. A.
75,
2699-2702[Abstract/Free Full Text]
|
| 22.
|
Robinson, A. C.,
Dean, D. R.,
and Burgess, B. K.
(1987)
J. Biol. Chem.
262,
14327-14332[Abstract/Free Full Text]
|
| 23.
|
Allen, R. M.,
Homer, M. J.,
Chatterjee, R.,
Ludden, P. W.,
Roberts, G. P.,
and Shah, V. K.
(1993)
J. Biol. Chem.
268,
23670-23674[Abstract/Free Full Text]
|
| 24.
|
Ludden, P. W.,
and Roberts, G. P.
(1989)
Curr. Top. Cell Regul.
30,
23-56[Medline]
[Order article via Infotrieve]
|
| 25.
|
Pope, M. R.,
Murrell, S. A.,
and Ludden, P. W.
(1985)
Proc. Natl. Acad. Sci. U. S. A.
82,
3173-3177[Abstract/Free Full Text]
|
| 26.
|
Lowery, R. G.,
Saari, L. L.,
and Ludden, P. W.
(1986)
J. Bacteriol.
166,
513-518[Abstract/Free Full Text]
|
| 27.
|
Lowery, R. G.,
and Ludden, P. W.
(1989)
Biochemistry
28,
4956-4961[CrossRef][Medline]
[Order article via Infotrieve]
|
| 28.
|
Lowery, R. G.,
and Ludden, P. W.
(1988)
J. Biol. Chem.
263,
16714-16719[Abstract/Free Full Text]
|
| 29.
|
Saari, L. L.,
Triplett, E. W.,
and Ludden, P. W.
(1984)
J. Biol. Chem.
259,
15502-15508[Abstract/Free Full Text]
|
| 30.
|
Pope, M. R.,
Saari, L. L.,
and Ludden, P. W.
(1986)
J. Biol. Chem.
261,
10104-10111[Abstract/Free Full Text]
|
| 31.
|
Saari, L. L.,
Pope, M. R.,
Murrell, S. A.,
and Ludden, P. W.
(1986)
J. Biol. Chem.
261,
4973-4977[Abstract/Free Full Text]
|
| 32.
|
Grunwald, S. K.,
Lies, D. P.,
Roberts, G. P.,
and Ludden, P. W.
(1995)
J. Bacteriol.
177,
628-635[Abstract/Free Full Text]
|
| 33.
|
Kanemoto, R. H.,
and Ludden, P. W.
(1984)
J. Bacteriol.
158,
713-720[Abstract/Free Full Text]
|
| 34.
|
Liang, J. H.,
Nielsen, G. M.,
Lies, D. P.,
Burris, R. H.,
Roberts, G. P.,
and Ludden, P. W.
(1991)
J. Bacteriol.
173,
6903-6909[Abstract/Free Full Text]
|
| 35.
|
Paul, T. D.,
and Ludden, P. W.
(1984)
Biochem. J.
224,
961-969[Medline]
[Order article via Infotrieve]
|
| 36.
|
Noren, A.,
and Nordlund, S.
(1994)
FEBS Lett.
356,
43-45[CrossRef][Medline]
[Order article via Infotrieve]
|
| 37.
|
Noren, A.,
Soliman, A.,
and Nordlund, S.
(1997)
Biochem. J.
322,
829-832
|
| 38.
|
Noren, A.,
and Nordlund, S.
(1997)
J. Bacteriol.
179,
7872-7874[Abstract/Free Full Text]
|
| 39.
|
Halbleib, C. M.,
and Ludden, P. W.
(1999)
Arch. Microbiol.
172,
51-58[CrossRef][Medline]
[Order article via Infotrieve]
|
| 40.
|
Fitzmaurice, W. P.,
Saari, L. L.,
Lowery, R. G.,
Ludden, P. W.,
and Roberts, G. P.
(1989)
Mol. Gen. Genet.
218,
340-347[CrossRef][Medline]
[Order article via Infotrieve]
|
| 41.
|
Nielsen, G. M.,
Bao, Y.,
Roberts, G. P.,
and Ludden, P. W.
(1994)
Biochem. J.
302,
801-806
|
| 42.
|
Ormerod, J. G.,
Ormerod, K. S.,
and Gest, H.
(1961)
Arch. Bioch. Biophys.
94,
449-463
|
| 43.
|
Ludden, P. W.,
and Burris, R. H.
(1978)
Biochem. J.
175,
251-259[Medline]
[Order article via Infotrieve]
|
| 44.
|
Grunwald, S. K.,
and Ludden, P. W.
(1997)
J. Bacteriol.
179,
3277-3283[Abstract/Free Full Text]
|
| 45.
|
Pope, M. R.,
Saari, L. L.,
and Ludden, P. W.
(1987)
Anal. Biochem.
160,
68-77[CrossRef][Medline]
[Order article via Infotrieve]
|
| 46.
|
Shah, V. K.,
and Brill, W. J.
(1973)
Biochim. Biophys. Acta
305,
445-454[Medline]
[Order article via Infotrieve]
|
| 47.
|
Ljones, T.
(1973)
Biochim. Biophys. Acta
321,
103-113[Medline]
[Order article via Infotrieve]
|
| 48.
|
Ludden, P. W.,
Lehman, L.,
and Roberts, G. P.
(1989)
J. Bacteriol.
171,
5210-5211[Abstract/Free Full Text]
|
| 49.
|
Zhang, Y.,
Burris, R. H.,
Ludden, P. W.,
and Roberts, G. P.
(1993)
J. Bacteriol.
175,
6781-6788[Abstract/Free Full Text]
|
| 50.
|
Zhang, Y.,
Burris, R. H.,
Ludden, P. W.,
and Roberts, G. P.
(1994)
J. Bacteriol.
176,
5780-5787[Abstract/Free Full Text]
|
| 51.
|
Preston, G. G.,
and Ludden, P. W.
(1982)
Biochem. J.
205,
489-494[Medline]
[Order article via Infotrieve]
|
| 52.
|
Pope, M. R.,
Murrell, S. A.,
and Ludden, P. W.
(1985)
Biochemistry
24,
2374-2380[CrossRef][Medline]
[Order article via Infotrieve]
|
| 53.
|
Ludden, P. W.,
and Burris, R. H.
(1976)
Science
194,
424-426[Abstract/Free Full Text]
|
| 54.
|
Nordlund, S.,
and Noren, A.
(1984)
Biochim. Biophys. Acta
791,
21-27
|
| 55.
|
Thorneley, R. N.,
and Deistung, J.
(1988)
Biochem. J.
253,
587-595 |